14
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      The Human Leukocyte Antigen Locus and Rheumatic Heart Disease Susceptibility in South Asians and Europeans

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Rheumatic heart disease (RHD), an autoinflammatory heart disease, was recently declared a global health priority by the World Health Organization. Here we report a genome-wide association study (GWAS) of RHD susceptibility in 1,163 South Asians (672 cases; 491 controls) recruited in India and Fiji. We analysed directly obtained and imputed genotypes, and followed-up associated loci in 1,459 Europeans (150 cases; 1,309 controls) from the UK Biobank study. We identify a novel susceptibility signal in the class III region of the human leukocyte antigen (HLA) complex in the South Asian dataset that clearly replicates in the Europeans (rs201026476; combined odds ratio 1.81, 95% confidence intervals 1.51–2.18, P = 3.48×10 −10). Importantly, this signal remains despite conditioning on the lead class I and class II variants ( P = 0.00033). These findings suggest the class III region is a key determinant of RHD susceptibility offering important new insight into pathogenesis while partly explaining the inconsistency of earlier reports.

          Related collections

          Most cited references26

          • Record: found
          • Abstract: found
          • Article: not found

          The global burden of group A streptococcal diseases.

          The global burden of disease caused by group A streptococcus (GAS) is not known. We review recent population-based data to estimate the burden of GAS diseases and highlight deficiencies in the available data. We estimate that there are at least 517,000 deaths each year due to severe GAS diseases (eg, acute rheumatic fever, rheumatic heart disease, post-streptococcal glomerulonephritis, and invasive infections). The prevalence of severe GAS disease is at least 18.1 million cases, with 1.78 million new cases each year. The greatest burden is due to rheumatic heart disease, with a prevalence of at least 15.6 million cases, with 282,000 new cases and 233,000 deaths each year. The burden of invasive GAS diseases is unexpectedly high, with at least 663,000 new cases and 163,000 deaths each year. In addition, there are more than 111 million prevalent cases of GAS pyoderma, and over 616 million incident cases per year of GAS pharyngitis. Epidemiological data from developing countries for most diseases is poor. On a global scale, GAS is an important cause of morbidity and mortality. These data emphasise the need to reinforce current control strategies, develop new primary prevention strategies, and collect better data from developing countries.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease.

            To identify the characteristics, treatment, and outcomes of contemporary patients with valvular heart disease (VHD) in Europe, and to examine adherence to guidelines. The Euro Heart Survey on VHD was conducted from April to July 2001 in 92 centres from 25 countries; it included prospectively 5001 adults with moderate to severe native VHD, infective endocarditis, or previous valve intervention. VHD was native in 71.9% of patients and 28.1% had had a previous intervention. Mean age was 64+/-14 years. Degenerative aetiologies were the most frequent in aortic VHD and mitral regurgitation while most cases of mitral stenosis were of rheumatic origin. Coronary angiography was used in 85.2% of patients before intervention. Of the 1269 patients who underwent intervention, prosthetic replacement was performed in 99.0% of aortic VHD, percutaneous dilatation in 33.9% of mitral stenosis, and valve repair in 46.5% of mitral regurgitation; 31.7% of patients had > or =1 associated procedure. Of patients with severe, symptomatic, single VHD, 31.8% did not undergo intervention, most frequently because of comorbidities. In asymptomatic patients, accordance with guidelines ranged between 66.0 and 78.5%. Operative mortality was <5% for single VHD. This survey provides unique contemporary data on characteristics and management of patients with VHD. Adherence to guidelines is globally satisfying as regards investigations and interventions.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Global, Regional, and National Burden of Rheumatic Heart Disease, 1990-2015.

              Rheumatic heart disease remains an important preventable cause of cardiovascular death and disability, particularly in low-income and middle-income countries. We estimated global, regional, and national trends in the prevalence of and mortality due to rheumatic heart disease as part of the 2015 Global Burden of Disease study.
                Bookmark

                Author and article information

                Contributors
                tom.parks@well.ox.ac.uk
                Journal
                Sci Rep
                Sci Rep
                Scientific Reports
                Nature Publishing Group UK (London )
                2045-2322
                2 June 2020
                2 June 2020
                2020
                : 10
                : 9004
                Affiliations
                [1 ]ISNI 0000 0004 0641 4511, GRID grid.270683.8, The Wellcome Centre for Human Genetics, University of Oxford, ; Oxford, Oxfordshire OX3 7BN UK
                [2 ]ISNI 0000 0004 0506 5997, GRID grid.440550.0, Department of Biotechnology, Babasaheb Bhimrao Ambedkar University, ; Lucknow, 226025 Uttar Pradesh India
                [3 ]ISNI 0000 0004 1936 8948, GRID grid.4991.5, MRC Population Health Research Unit, Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, ; Oxford, Oxfordshire OX3 7LF UK
                [4 ]ISNI 0000 0000 9346 7267, GRID grid.263138.d, Department of Cardiology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, ; Lucknow, 226014 Uttar Pradesh India
                [5 ]ISNI 0000 0004 1767 6103, GRID grid.413618.9, Department of Cytogenetics/Anatomy, All India Institute of Medical Sciences, ; New Delhi 110029 Delhi, India
                [6 ]ISNI 0000 0004 0455 8044, GRID grid.417863.f, Department of Medical Science, Fiji National University, ; Suva, PO Box 7222, Viti Levu, Fiji
                [7 ]ISNI 0000 0000 9442 535X, GRID grid.1058.c, Tropical Infectious Diseases, Murdoch Children’s Research Institute, ; Melbourne, Victoria 3052 Australia
                [8 ]ISNI 0000 0004 0425 469X, GRID grid.8991.9, Department of Clinical Research, London School of Hygiene & Tropical Medicine, ; London, Greater London WC1E 7HT UK
                Author information
                http://orcid.org/0000-0002-7583-2886
                http://orcid.org/0000-0002-4502-2209
                http://orcid.org/0000-0003-3121-4397
                http://orcid.org/0000-0002-3511-3297
                http://orcid.org/0000-0003-0900-9629
                http://orcid.org/0000-0002-1163-8654
                Article
                65855
                10.1038/s41598-020-65855-8
                7265443
                32488134
                a08d27f5-657a-4359-8386-574fa6101063
                © The Author(s) 2020

                Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

                History
                : 4 November 2019
                : 7 May 2020
                Funding
                Funded by: FundRef https://doi.org/10.13039/501100000274, British Heart Foundation (BHF);
                Award ID: RE/13/1/30181
                Award ID: PG/14/26/30509
                Award Recipient :
                Funded by: FundRef https://doi.org/10.13039/501100000374, British Medical Association (BMA);
                Award ID: Josephine Lansdell Grant 2018
                Award ID: Josephine Lansdell Grant 2012
                Award Recipient :
                Funded by: FundRef https://doi.org/10.13039/501100000272, DH | National Institute for Health Research (NIHR);
                Award ID: ACF-2016-20-001
                Award Recipient :
                Funded by: FundRef https://doi.org/10.13039/501100000265, RCUK | Medical Research Council (MRC);
                Award ID: G1100449
                Award Recipient :
                Categories
                Article
                Custom metadata
                © The Author(s) 2020

                Uncategorized
                genome-wide association studies,immunogenetics
                Uncategorized
                genome-wide association studies, immunogenetics

                Comments

                Comment on this article